Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated with Lenvatinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated with Lenvatinib

Published:2015-11 Issue:11 Volume:25 Page:1262-1264
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Danilovic Debora Lucia Seguro¹²,de Camargo Rosalinda Yossie Asato²,Castro Gilberto³,Papadia Carla¹,Marui Suemi²,Hoff Ana Oliveira¹

Affiliation:

1. Department of Endocrinology, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.

2. Laboratório de Endocrinologia Celular e Molecular (LIM25), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

3. Department of Oncology, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2015.0167

Reference4 articles.

1. 3,5,3′-Triiodothyronine Thyrotoxicosis due to Increased Conversion of Administered Levothyroxine in Patients with Massive Metastatic Follicular Thyroid Carcinoma

2. Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

3. Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases

4. Sunitinib-Induced Hypothyroidism Is due to Induction of Type 3 Deiodinase Activity and Thyroidal Capillary Regression

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and outcome of patients with Graves’ disease and metastatic differentiated thyroid cancer;Radiology and Oncology;2023-09-01

2. Treatment and Outcome of Patients with Graves' Disease and Metastatic Differentiated Thyroid Cancer;2023-01-04

3. Tumor progression with thyrotoxicosis on differentiated thyroid carcinoma due to thyrotropin receptor stimulation: is tyrosine kinase inhibitors the cause of thyroid stimulating hormone receptor antibody positivity?;Annals of Palliative Medicine;2022-09

4. “An Unexpected Turn of Events After Discontinuing Tyrosine Kinase Inhibitor Use”;Clinical Thyroidology;2022-04-01

5. Hyperthyroidism and Thyrotoxicosis;Endocrinology and Diabetes;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3